世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 COVID-19診断の世界市場規模、現状、予測2022-2028年Global COVID-19 Diagnosis Market Size, Status and Forecast 2022-2028 COVID-19パンデミックは、WHOによって世界的な健康危機として宣言されており、第二次世界大戦以降、人類が直面した最大の課題の一つです。2019年12月末までに中国の武漢で出現した後、2020年の第1四半期までに184... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーCOVID-19パンデミックは、WHOによって世界的な健康危機として宣言されており、第二次世界大戦以降、人類が直面した最大の課題の一つです。2019年12月末までに中国の武漢で出現した後、2020年の第1四半期までに184カ国にウイルスが広がっています。アメリカ大陸、ヨーロッパ、アフリカでは、感染の発生率が日々増加していることが観察されています。コロナウイルスはこれまでにもいくつかの株が確認され、研究されてきましたが、今回の病気は新型の株が原因で発生し、高いRナートによりあっという間にパンデミックになってしまいました。このウイルスは、各国の社会経済や政治に影響を与え、結果として経済に悪影響を及ぼすことが予想されます。最新の調査によると、COVID-19診断の世界市場規模は、分析期間中にCAGR %で成長し、2028年にはUSD 100万に達する見込みです。 世界のCOVID-19診断の範囲と市場規模 当レポートでは、世界の「COVID-19診断」の現状、将来予測、成長機会、主要市場、主要企業に焦点を当てています。調査目的は、北米、欧州、中国、日本、東南アジア、インド、中南米などにおけるCOVID-19診断の開発を提示することです。 タイプ別セグメント RT-PCR 等温核酸増幅法（Isothermal Nucleic Acid Amplification その他 アプリケーション別 病院 研究所 地域別 北アメリカ 欧州 中国 日本 東南アジア インド 中央・南アメリカ 会社別 Cepheid アボット メサ・バイオテック マイクロセンスDx ジェンマーク・ダイアグノスティックス クレド 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global COVID-19 Diagnosis Market Size Growth Rate by Type (2022-2028) 1.2.2 RT-PCR 1.2.3 Isothermal Nucleic Acid Amplification 1.2.4 Others 1.3 Market by Application 1.3.1 Global COVID-19 Diagnosis Market Share by Application (2022-2028) 1.3.2 Hospital 1.3.3 Laboratory 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global COVID-19 Diagnosis Market Size 2.2 COVID-19 Diagnosis Market Size by Regions 2.2.1 COVID-19 Diagnosis Growth Rate by Regions (2022-2028) 2.2.2 COVID-19 Diagnosis Market Share by Regions (2022-2028) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases 3 Key Players 3.1 COVID-19 Diagnosis Revenue by Players (2022 & 2028) 3.2 COVID-19 Diagnosis Key Players Headquarters and Area Served 3.3 Key Players COVID-19 Diagnosis Product/Solution/Service 3.4 Date of Enter into COVID-19 Diagnosis Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application 4.1 Global COVID-19 Diagnosis Market Size by Type (2022-2028) 4.2 Global COVID-19 Diagnosis Market Size by Application (2022-2028) 5 North America 5.1 North America COVID-19 Diagnosis Market Forecast (2022-2028) 5.2 COVID-19 Diagnosis Key Players in North America 5.3 North America COVID-19 Diagnosis Market Size by Type 5.4 North America COVID-19 Diagnosis Market Size by Application 6 Europe 6.1 Europe COVID-19 Diagnosis Market Forecast (2022-2028) 6.2 COVID-19 Diagnosis Key Players in Europe 6.3 Europe COVID-19 Diagnosis Market Size by Type 6.4 Europe COVID-19 Diagnosis Market Size by Application 7 Asia-Pacific 7.1 Asia-Pacific COVID-19 Diagnosis Market Forecast (2022-2028) 7.2 COVID-19 Diagnosis Key Players in Asia-Pacific 7.3 Asia-Pacific COVID-19 Diagnosis Market Size by Type 7.4 Asia-Pacific COVID-19 Diagnosis Market Size by Application 8 Rest of World 8.1 Latin America 8.1.1 Latin America COVID-19 Diagnosis Market Analysis 8.1.2 Key Players in Latin America 8.2 Middle East & Africa 8.2.1 Middle East & Africa COVID-19 Diagnosis Market Analysis 8.2.2 Key Players in Middle East & Africa 9 International Player Profiles 9.1 Cepheid 9.1.1 Cepheid Company Details 9.1.2 Cepheid Description and Business Overview 9.1.3 Cepheid COVID-19 Diagnosis Introduction 9.1.4 Cepheid Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.1.5 Cepheid Recent Development 9.2 Abbott 9.2.1 Abbott Company Details 9.2.2 Abbott Description and Business Overview 9.2.3 Abbott COVID-19 Diagnosis Introduction 9.2.4 Abbott Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.2.5 Abbott Recent Development 9.3 Mesa Biotech 9.3.1 Mesa Biotech Company Details 9.3.2 Mesa Biotech Description and Business Overview 9.3.3 Mesa Biotech COVID-19 Diagnosis Introduction 9.3.4 Mesa Biotech Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.3.5 Mesa Biotech Recent Development 9.4 Microsens Dx 9.4.1 Microsens Dx Company Details 9.4.2 Microsens Dx Description and Business Overview 9.4.3 Microsens Dx COVID-19 Diagnosis Introduction 9.4.4 Microsens Dx Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.4.5 Microsens Dx Recent Development 9.5 GenMark Diagnostics 9.5.1 GenMark Diagnostics Company Details 9.5.2 GenMark Diagnostics Description and Business Overview 9.5.3 GenMark Diagnostics COVID-19 Diagnosis Introduction 9.5.4 GenMark Diagnostics Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.5.5 GenMark Diagnostics Recent Development 9.6 Credo 9.6.1 Credo Company Details 9.6.2 Credo Description and Business Overview 9.6.3 Credo COVID-19 Diagnosis Introduction 9.6.4 Credo Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.6.5 Credo Recent Development 10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints 11 Key Findings in This Report 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details
SummaryThe COVID-19 pandemic has been declared as a global health crisis by WHO and is one of the greatest challenges ever faced by mankind since World War II. After its emergence in Wuhan, China by the end of December 2019, the virus has spread across 184 countries through the first quarter of 2020. Incidence of the infection is observed to be increasing daily in the Americas, Europe, and Africa. Although several strains of coronavirus have been identified and studied earlier, the new disease has been caused due to a novel strain and in no time turned into a pandemic due to a high R-naught. The virus is expected to impact the socioeconomic and political landscape of the countries, consequently leading to adverse economic impact. Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global COVID-19 Diagnosis Market Size Growth Rate by Type (2022-2028) 1.2.2 RT-PCR 1.2.3 Isothermal Nucleic Acid Amplification 1.2.4 Others 1.3 Market by Application 1.3.1 Global COVID-19 Diagnosis Market Share by Application (2022-2028) 1.3.2 Hospital 1.3.3 Laboratory 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global COVID-19 Diagnosis Market Size 2.2 COVID-19 Diagnosis Market Size by Regions 2.2.1 COVID-19 Diagnosis Growth Rate by Regions (2022-2028) 2.2.2 COVID-19 Diagnosis Market Share by Regions (2022-2028) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases 3 Key Players 3.1 COVID-19 Diagnosis Revenue by Players (2022 & 2028) 3.2 COVID-19 Diagnosis Key Players Headquarters and Area Served 3.3 Key Players COVID-19 Diagnosis Product/Solution/Service 3.4 Date of Enter into COVID-19 Diagnosis Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application 4.1 Global COVID-19 Diagnosis Market Size by Type (2022-2028) 4.2 Global COVID-19 Diagnosis Market Size by Application (2022-2028) 5 North America 5.1 North America COVID-19 Diagnosis Market Forecast (2022-2028) 5.2 COVID-19 Diagnosis Key Players in North America 5.3 North America COVID-19 Diagnosis Market Size by Type 5.4 North America COVID-19 Diagnosis Market Size by Application 6 Europe 6.1 Europe COVID-19 Diagnosis Market Forecast (2022-2028) 6.2 COVID-19 Diagnosis Key Players in Europe 6.3 Europe COVID-19 Diagnosis Market Size by Type 6.4 Europe COVID-19 Diagnosis Market Size by Application 7 Asia-Pacific 7.1 Asia-Pacific COVID-19 Diagnosis Market Forecast (2022-2028) 7.2 COVID-19 Diagnosis Key Players in Asia-Pacific 7.3 Asia-Pacific COVID-19 Diagnosis Market Size by Type 7.4 Asia-Pacific COVID-19 Diagnosis Market Size by Application 8 Rest of World 8.1 Latin America 8.1.1 Latin America COVID-19 Diagnosis Market Analysis 8.1.2 Key Players in Latin America 8.2 Middle East & Africa 8.2.1 Middle East & Africa COVID-19 Diagnosis Market Analysis 8.2.2 Key Players in Middle East & Africa 9 International Player Profiles 9.1 Cepheid 9.1.1 Cepheid Company Details 9.1.2 Cepheid Description and Business Overview 9.1.3 Cepheid COVID-19 Diagnosis Introduction 9.1.4 Cepheid Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.1.5 Cepheid Recent Development 9.2 Abbott 9.2.1 Abbott Company Details 9.2.2 Abbott Description and Business Overview 9.2.3 Abbott COVID-19 Diagnosis Introduction 9.2.4 Abbott Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.2.5 Abbott Recent Development 9.3 Mesa Biotech 9.3.1 Mesa Biotech Company Details 9.3.2 Mesa Biotech Description and Business Overview 9.3.3 Mesa Biotech COVID-19 Diagnosis Introduction 9.3.4 Mesa Biotech Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.3.5 Mesa Biotech Recent Development 9.4 Microsens Dx 9.4.1 Microsens Dx Company Details 9.4.2 Microsens Dx Description and Business Overview 9.4.3 Microsens Dx COVID-19 Diagnosis Introduction 9.4.4 Microsens Dx Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.4.5 Microsens Dx Recent Development 9.5 GenMark Diagnostics 9.5.1 GenMark Diagnostics Company Details 9.5.2 GenMark Diagnostics Description and Business Overview 9.5.3 GenMark Diagnostics COVID-19 Diagnosis Introduction 9.5.4 GenMark Diagnostics Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.5.5 GenMark Diagnostics Recent Development 9.6 Credo 9.6.1 Credo Company Details 9.6.2 Credo Description and Business Overview 9.6.3 Credo COVID-19 Diagnosis Introduction 9.6.4 Credo Revenue in COVID-19 Diagnosis Business (2022 & 2028) 9.6.5 Credo Recent Development 10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints 11 Key Findings in This Report 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD（）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
